Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy
Anton N. Bokatyi(Kurchatov Institute), Yury А. Skorik(Institute of Macromolecular Compounds), Artem Rubinstein(Institute of Experimental Medicine), Natallia V. Dubashynskaya(Institute of Macromolecular Compounds), I. V. Kudryavtsev(Far Eastern Federal University), E. N. Vlasova(Institute of Macromolecular Compounds), Andrey S. Trulioff(Institute of Experimental Medicine)
Cited by 3
Related Papers
Chemical modification of hyaluronic acid as a strategy for the development of advanced drug delivery systems
|Carbohydrate Polymers|2024|129
Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects
|Biomedicines|2021|54
Mucoadhesive cholesterol-chitosan self-assembled particles for topical ocular delivery of dexamethasone
|International Journal of Biological Macromolecules|2020|36
Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery
|International Journal of Molecular Sciences|2021|30
Hyaluronan-colistin conjugates: Synthesis, characterization, and prospects for medical applications
|International Journal of Biological Macromolecules|2022|20